Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2011-01-18
2011-01-18
Reddig, Peter J (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S007100, C435S007210, C435S007230, C530S388100, C530S388240, C530S388800, C530S388850
Reexamination Certificate
active
07871762
ABSTRACT:
The invention provides methods for detecting the presence or absence of invasive trophoblast cells. In addition, the invention provides methods for distinguishing quiescent trophoblast diseases from invasive trophoblast diseases and methods for monitoring progression of quiescent trophoblast diseases. The invention provides methods for detecting the presence or absence of germ cell tumors.
REFERENCES:
patent: 6927034 (2005-08-01), O'Connor et al.
Cole, LA et al., Prenatal Diagnosis, 1999, 19:351-359.
Kobata, A, Biochimie, 1988, 70:1575-1585.
Bowie et al (Science, 1990, 257:1306-1310).
Burgess et al (J of Cell Bio. 111:2129-2138, 1990).
Lazar et al (Molecular and Cellular Biology, 1988, 8:1247-1252).
Birken (Tumor Biology 2005 26:131-141).
Pandian et al. (Clin. Chem. 2003 49(5): 808-810) teach.
Cole and Sutton (J. Reproductive Med. 2004 49(7): 545-53).
Stites et al. (Medical Immunology, 9th Ed, Appleton and Lange, 1997, pp. 250-251).
Khanlian et al. (American J. of Obstetrics and Gynecology May 2003 188:1254-9).
Elliott et al, “Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma”Endocrine(1997) 7:15-32.
Cole et al.; “Utility of commonly used commercial human chorionic gonadotropin immunoassays in thee diagnosis and management of trophoblastic diseases”Clinical Chemistry(2001) 47:308-315.
Cole LA. Phantom hCG and phantom choriocarcinoma. Gynecol Oncol 1998; 71:325-329.
Rotmensch S, Cole LA. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 2000; 355:712-715.
Cole LA, Shahabi S, Butler S, Mitchell H, Newlands E, Behrman HR, Verrill HL. Utility of commonly used commercial hCG immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem 2001; 47:308-315.
Cole LA, Butler SA. False positive or phantom hCG result: a serious problem. Clin Lab Intl 2001; 25:9-14.
Cole LA, Butler SA. Detection of hCG in Trophoblastic Disease: The USA hCG Reference Service experience. J Reprod Med 2002; 47:433-444.
Butler SA, Cole LA. The Use of heterophilic antibody blocking agent (HBT) in reducing false positive hCG results. Clin Chem 2001; 47:1332-1333.
Butler SA, Cole LA. Falsely elevated hCG leading to unnecessary therapy (letter). Obstet Gynecol 99:516-517, 2002.
Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MI. Hyperglycosylated hCG (invasive trophoblast antigen) immunoassay: a new basis for gestational down syndrome screening. Clin Chem 1999; 45:2109-2119.
Suzuki T, Goto S, Nawa A, Kurauchi 0, Saito M, Tomoda Y. Identification of the pregnancy responsible for gestational trophoblastic disease by DNA analysis. Obstet Gynecol 1993:82, 629-34.
Kohorn El. Persistent low-level ‘real’ human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma. Gynecol Oncol 2002; 85:315-320.
Newlands -ES. Presentation and management of persistent gestational trophoblastic disease and gestational trophoblastic tumors in the UK. In: Hancock BW, Newland ES, Berkowitz RS, editors. Gestational Trophoblastic Disease. London: Chapman and Hall; 1997. p. 143-156.
Berkowitz RS, Goldstein DP. Presentation and management of molar pregnancy. In: Hancock BW, Newland ES, Berkowitz RS, editors. Gestational Trophoblastic Disease. London: Chapman and Hall; 1997. p. 127-142.
O'Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenat Diagn 1998; 18:1232-1240.
Elliott MM, Kardana A, Lustbader JW, Cole LA. Carbohydrate and peptide structure of the a- and (3-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 7, 15-32, 1997.
Cole LA, Kardana A, Park S-Y, Braunstein GD, “The Deactivation of hCG by Nicking and Dissociation” Journal of Endocrinology and Metabolism 1993; 76:704-710.
Cole LA, “Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites”, Clinical Chemistry 1997; 43:2233-2243.
Norman RJ, Buck RH, De Medeiros SF, “Measurement of human chorionic gonadotropin (hCG) :indications and techniques for the clinical laboratory” Ann. Clin. Biochem. 1990; 27:183-194.
Sturgeon CM, McAllister EJ, “Analysis of hCG: clinical applications and assay requirements” Ann. Clin. Biochem. 1998; 35: 460-491.
Coleman Henry D.
Reddig Peter J
Sapone William J.
STC.UNM
Sudol R. Neil
LandOfFree
Hyperglycosylated hCG (invasive trophoblast antigen) in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hyperglycosylated hCG (invasive trophoblast antigen) in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyperglycosylated hCG (invasive trophoblast antigen) in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2627228